PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31319135-5	2019	Reduced expression of NADPH dehydrogenase quinone 1 (NQO-1) and heme oxygenase 1 (HO-1) genes, which are well-characterized downstream targets of Nrf2-mediated transactivation, was also confirmed by using ALA and another Nrf2 activator, marliolide.	marliolide	237-247	NFE2 like bZIP transcription factor 2	Homo sapiens	146-150	
31319135-8	2019	Interestingly, pretreatment of either ALA or marliolide conferred protection against the ROS induction and the subsequent development of cytotoxicity by menadione in both HaCaT and iHFK cells regardless of the Nrf2 status.	marliolide	45-55	NFE2 like bZIP transcription factor 2	Homo sapiens	210-214	
31319135-9	2019	These data suggest a possibility for activation of Nrf2-independent ROS detoxification pathways by either ALA or marliolide.	marliolide	113-123	NFE2 like bZIP transcription factor 2	Homo sapiens	51-55	
29525432-0	2018	Marliolide inhibits skin carcinogenesis by activating NRF2/ARE to induce heme oxygenase-1.	marliolide	0-10	NFE2 like bZIP transcription factor 2	Homo sapiens	54-58	
29525432-4	2018	Mechanism-based studies demonstrated that the induction of HO-1 by marliolide occurred through activation of NRF2/ARE via direct binding of marliolide to KEAP1.	marliolide	67-77	NFE2 like bZIP transcription factor 2	Homo sapiens	109-113	
29525432-4	2018	Mechanism-based studies demonstrated that the induction of HO-1 by marliolide occurred through activation of NRF2/ARE via direct binding of marliolide to KEAP1.	marliolide	140-150	NFE2 like bZIP transcription factor 2	Homo sapiens	109-113